Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows
Wednesday, July 5, 2017 - 22:32
in Health & Medicine
A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists.